NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06/26/2026
Back to search
Official data from USPTO
ALIVAMAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ALIVAMAB
ST13
US500000088975328Class
31, 42
Filing
88975328
Registration
5880246
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
06/26/2026
Trademark type
Word
Nice classes
31, 42
Filing date
12/21/2018
Registration date
10/08/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/26/2026
Last transaction
06/26/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
2010-06-00
First use in commerce
12/09/2018
Drawing code
4
Owner type
16
Owner location
San Diego, CA, US
Examiner
FATHY, DOMINIC
Current location
Historical data usage
Holders and representatives
Holders
Ablexis, LLC
Representatives
Michelle Levin Leason Ellis LLP
Technical classification
Nice Classes
Class 31Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 31
Live animalstransgenic mice for use in scientificmedicalpharmaceuticalagriculturalindustrial research
Class 42
Computer and scientific servicesantibody drug discovery services
Publications
History of USPTO decisions and trademark events.
24 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
06/26/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/26/2026
ES8R
TEAS SECTION 8 RECEIVED
03/19/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/08/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
10/08/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/23/2019
PUBO
PUBLISHED FOR OPPOSITION
07/23/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/03/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/14/2019
DPCC
DIVISIONAL PROCESSING COMPLETE
05/29/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/28/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/28/2019
ALIE
ASSIGNED TO LIE
05/17/2019
DRRR
DIVISIONAL REQUEST RECEIVED
05/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/10/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/10/2019
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
05/10/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/20/2019
GNRT
NON-FINAL ACTION E-MAILED
03/20/2019
CNRT
NON-FINAL ACTION WRITTEN
03/20/2019
DOCK
ASSIGNED TO EXAMINER
03/18/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/14/2019
NWAP
NEW APPLICATION ENTERED
12/25/2018
Continuous trademark protection
Get notified about every new filing that threatens ALIVAMAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.